Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer

    NEXT STORY
    Global Pediatric Vaccine Market Will Reach to USD 56.28 Billion By 2025: Zion Market Research
    PREV STORY
    iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Bio-Path Holdings Appoints Mark Colonnese to its Board of Directors

    HOUSTON, July 17, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control

    GAITHERSBURG, Md., June 05, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced the ...

    author_avatar
    NASDAQ Market News

    Argos Therapeutics Announces $6,000,000 Secured Convertible Note Financing

    DURHAM, N.C., June 16, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), an immuno-oncology ...

    author_avatar
    NASDAQ Market News